*Correspondence: Mathias Hallberg, [email protected] This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Gut-brain axis effects: Research suggests BPC-157 influences the gut-brain axis, potentially explaining reported cognitive and mood benefits alongside physical healing
of Montral received the original Notice of Compliance from Health Canada on April 29, 2014 for the 2 mg/vial Egrifta presentation, followed by a 1 mg/vial supplementary approval in March 2015
Professor Guido Schoenenberger of the University of Basel, one of the key scientists to have worked on DSIP, disagreed
Comparative efficacy In human clinical studies, epitalon and epithalamin both significantly increased telomere lengths in elderly patients aged 60 to 65 and 75 to 80
